Quarterly report pursuant to Section 13 or 15(d)

11. Related Party Transactions

v3.8.0.1
11. Related Party Transactions
9 Months Ended
Sep. 30, 2017
Related Party Transactions [Abstract]  
Related Party Transactions

The Company has entered into various research, development, license and supply agreements with Pharmsynthez (including SynBio), and Serum Institute, each a related party whose relationship and ownership has not materially changed from that disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 31, 2017, as amended on May 1, 2017.